Amlodipine Besylate Tablet
Product Images NDC 68071-3698

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 68071-3698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3698 9)

This text provides detailed information about a medication called Amlodipine Besylate 10mg tablets, including the manufacturer, lot number, expiration date, physical description, dosage information, and safety warnings. It also includes instructions to consult a doctor for medical advice and how to report side effects to the FDA. Additionally, there is a warning to keep the medication out of reach of children and store it at a controlled temperature between 68-77°F.*

FDA Label Image

Amlodipine Besylate (99f197ee 0a14 4981 A816 A1570a5a8da7 01)

FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

The text provides information about an event rate analysis comparing Amlodipine versus Placebo through Kaplan-Meier Analysis. It includes a p-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval ranging from 0.54 to 0.88. The data is presented graphically in Figure 1, showing the composite clinical outcomes over time (measured in months) for Amlodipine and Placebo.*

FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)

This document outlines a comparison between the effects of Amlodipine and Placebo in a study involving 1318 patients. The analysis includes data related to gender distribution, baseline systolic blood pressure, the presence of vessel disease and stenosis, and the use of PCI with or without stent placement. Additionally, it reports hazard ratios with 95% confidence intervals for the studied parameters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.